Related Experiment Videos
Oral antibiotic therapy of skeletal infections in children
Insights
This study found that oral antibiotics are as safe and effective as intravenous (IV) antibiotics for treating pediatric osteomyelitis and septic arthritis. Carefully monitored oral therapy offers a successful alternative for acute skeletal infections.
Area of Science:
- Pediatric Infectious Diseases
- Orthopedic Surgery
- Pharmacology
Background:
- Osteomyelitis and septic arthritis are serious bone and joint infections in children.
- Intravenous (IV) antibiotic therapy has been the standard treatment, often requiring prolonged hospitalization.
- The potential for oral antibiotic therapy to provide a safe and effective alternative warrants investigation.
Purpose of the Study:
- To compare the efficacy and safety of oral versus IV antibiotic regimens in children with skeletal infections.
- To evaluate clinical outcomes and relapse rates in both treatment groups.
Main Methods:
- A prospective study involving 15 children with defined osteomyelitis and/or septic arthritis.
- Patients initially received IV antibiotics, with seven transitioned to oral therapy within 72 hours.
- Oral antibiotic doses were adjusted to achieve a peak serum bactericidal titer ≥ 1:8.
- All patients received a minimum of six weeks of therapy, with monitoring of clinical course and erythrocyte sedimentation rate (ESR).
Main Results:
- Clinical courses and outcomes were similar between the oral and IV antibiotic groups.
- No treatment failures or relapses were observed during a 12-month follow-up period.
- The erythrocyte sedimentation rate (ESR) was a key monitoring parameter.
Conclusions:
- Carefully monitored oral antibiotic therapy is a safe and successful treatment option for acute skeletal infections in children.
- This study provides controlled data supporting the transition from IV to oral antibiotics.
- Oral therapy may reduce the need for prolonged hospitalization in pediatric patients with osteomyelitis and septic arthritis.
Abstract:
Oral and intravenous (IV) antibiotic regimens were compared in 15 children with etiologically defined osteomyelitis and/or septic arthritis. On admission all children were started on standard IV therapy; seven were changed to oral antibiotics within 72 hours and the remaining eight continued on IV therapy for four weeks. Oral antibiotic doses were adjusted to achieve a peak serum bactericidal titer of greater than or equal to 1:8 against the patient's own pathogen. All patients were treated in hospital for four weeks; therapy continued for a minimum of six weeks or until the erythrocyte sedimentation rate (ESR) fell below 20 mm/hr. The clinical course and outcome were similar in both groups. There were no treatment failures nor any relapses during a 12-month follow-up period. This prospective study supports, with controlled data, the concept that acute skeletal infections can be safely and successfully treated with carefully monitored oral therapy.